Connection

Sergey Moiseev to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Sergey Moiseev has written about Antibodies, Monoclonal, Humanized.
Sergey Moiseev
Connection Strength
0.086
Antibodies, Monoclonal, Humanized
  1. The complement inhibitors in COVID-19: future expectations. Eur Rev Med Pharmacol Sci. 2020 06; 24(12):6480-6481.
    View in: PubMed
    Score: 0.045
  2. Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis. J Allergy Clin Immunol. 2019 08; 144(2):621.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.